⏳ Fetching live dividend data...
Home › Calculator › SLN Dividend Calculator 2026
Silence Therapeutics plc · NASDAQ
Price: $6.90 · Annual div: $2.00/share · Frequency: quarterly · Payout ratio: 50% · Ex-div: TBD
Click to apply scenario to the calculator
Year your monthly dividend income covers each expense (based on current settings)
$10,000 in SLN → $15964181.60M in 10 years · $1,325,881,385,798.91/month
Silence Therapeutics plc, a biotechnology company, focuses on the discovery and development of novel ribonucleic acid (RNA) therapeutics in hematology, cardiovascular, and other rare and metabolic indications. The company's platform includes mRNAi GalNAc Oligonucleotide Discovery platform designed to accurately target specific disease-associated genes in the liver. It designs short interfering RNA molecules to harness the body's natural mechanism of RNA interference, and degrading messenger RNA molecules that encode specific targeted disease-associated proteins in a cell. The company is developing various product candidates, including SLN360, which is Phase I clinical trials for the treatment of cardiovascular disease with high lipoprotein; SLN124 that is in Phase I clinical trials for the treatment of non-transfusion dependent thalassemia, and Phase I clinical trials for the treatment of myelodysplastic syndrome; and SLN124 for the treatment of polycythemia vera. It has collaboration agreements with AstraZeneca PLC to discover, develop, and commercialize small interfering RNA therapeutics for the treatment of cardiovascular, renal, metabolic, and respiratory diseases; and Mallinckrodt Pharma IP Trading DAC to develop and commercialize RNAi drug targets designed to silence the complement cascade in complement-mediated disorders. The company also has a collaboration with Hansoh Pharmaceutical Group Company Limited to develop siRNAs for three undisclosed targets leveraging Silence's mRNAi GOLD platform. The company was formerly known as SR Pharma plc and changed its name to Silence Therapeutics plc in May 2007. Silence Therapeutics plc is headquartered in London, the United Kingdom.
This calculation uses the DividendFlow Engine v6.0. Data is verified daily against SEC filings and FMP real-time feeds to ensure projection accuracy.
We'll send you a full breakdown of your projections, DRIP tips, and how to enable dividend reinvestment with your broker.
Free forever. No spam. Unsubscribe anytime. · Privacy Policy
Ready to invest? Open SLN position with:
Real after-tax yield depends on where you live and how you hold SLN.
| Account/Country | Tax Rate | After-tax Yield | Real Yield | $10K Annual Income |
|---|---|---|---|---|
| 🇺🇸 Roth IRA / 401k | 0% | 28.99% | 26.19% | $2,899 / yr |
| 🇺🇸 US Taxable (15%) ✓ | 15% | 24.64% | 21.84% | $2,464 / yr |
| 🇺🇸 US Taxable (20%) | 20% | 23.19% | 20.39% | $2,319 / yr |
| 🇬🇧 UK ISA | 0% | 28.99% | 26.19% | $2,899 / yr |
| 🇬🇧 UK Taxable | 8.75% | 26.45% | 23.65% | $2,645 / yr |
| 🇨🇦 TFSA | 0% | 28.99% | 26.19% | $2,899 / yr |
| 🇨🇦 CA Taxable | 25% | 21.74% | 18.94% | $2,174 / yr |
| 🇦🇺 Super (pension) | 15% | 24.64% | 21.84% | $2,464 / yr |
| 🇦🇺 AU Taxable | 30% | 20.29% | 17.49% | $2,029 / yr |
| 🇩🇪 DE Taxable | 26.375% | 21.34% | 18.54% | $2,134 / yr |
| 🇫🇷 FR Taxable | 30% | 20.29% | 17.49% | $2,029 / yr |
Real yield = after-tax yield minus US CPI of 2.8%. 12-month CPI (US BLS via FMP economic-indicators). Click any row to select. US withholding tax (30%, reducible by treaty) applies to non-US residents holding US stocks in taxable accounts.
12-month CPI (US BLS via FMP economic-indicators).
Based on current dividend of $2.00/share/yr · 🇺🇸 US Taxable (15%) · static projection (no growth assumed).
SLN pays quarterly — 4 times per year. Next ex-div: TBD.
How SLN compares to typical Healthcare averages.
Benchmarks: S&P 500 sector averages (2024–2026). Sources: Morningstar, Bloomberg, NAREIT. 5Y CAGR for SLN sourced from FMP /financial-growth endpoint — real data, not estimates.
When executives buy their own stock, it's a signal they believe in the dividend's sustainability.
| Insider | Title | Type | Date | Shares | Price | Total Value |
|---|---|---|---|---|---|---|
| Buy | 2025-08-03 | 20,000 | $5.45 | $109.0K | ||
| Buy | 2025-10-27 | 2,000 | $7.75 | $15.5K | ||
| Sale | 2025-10-27 | 2,000 | $7.75 | $15.5K | ||
| Sale | 2025-08-03 | 20,000 | $5.45 | $109.0K | ||
| A-Award | 2026-01-02 | 90,000 | $2.05 | $184.5K | ||
| A-Award | 2026-01-02 | 90,000 | $2.05 | $184.5K | ||
| A-Award | 2026-01-02 | 300,000 | $2.05 | $615.0K | ||
| A-Award | 2026-01-02 | 375,000 | $2.05 | $768.8K | ||
| A-Award | 2026-01-02 | 90,000 | $2.05 | $184.5K | ||
| A-Award | 2025-12-18 | 900,000 | $2.08 | $1.87M |
Insider transactions sourced from SEC Form 4 filings via Financial Modeling Prep. See disclaimer.
Analyst consensus price target via FMP. Not a guarantee of future performance. Past analyst accuracy varies.
Altman Z-Score predicts bankruptcy risk. Piotroski F-Score measures financial strength across 9 criteria. High scores → lower dividend cut risk. Data via FMP financial statements.
Revenue breakdown from latest annual report via FMP. Percentages may not sum to 100% due to rounding.
Dividend yields, payout ratios, and financial metrics are sourced from Financial Modeling Prep (FMP) and cross-referenced with SEC EDGAR filings. Data is cached and updated every 24 hours via our nightly refresh. DRIP projections are forward-looking estimates, not guarantees.
Educational purposes only. Not financial advice. DividendFlow is not a registered investment advisor. Projections generated by the SLN dividend calculator are estimates based on historical data and user inputs. Actual future returns, stock prices, and dividend payments will vary. Dividends can be cut or suspended at any time. All investments carry risk, including the loss of principal. Please consult a qualified financial professional before making any investment decisions. Full disclaimer →
Real users. No sign-up required to leave a review.
“Finally a free dividend calculator that doesn't make me sign up or connect my brokerage. Entered SCHD and got the full DRIP projection in seconds. Bookmarked immediately.”
“I've been trying to figure out how much dividend income I'd need to retire. This tool showed me exactly — $400K in JEPI at 7% yield gives me $2,333/month. No calculator did that this clearly before.”
“Really solid passive income calculator. Covers everything: DRIP compounding, Roth IRA tax savings, DCA contributions. The year-by-year breakdown is what I was missing from other tools.”
“As someone planning retirement in 5 years, this dividend yield calculator showed me I need about 12% more in dividend stocks to hit my income target. Incredibly useful and completely free.”
“The Congress trades tracker is genius. Saw that several senators were buying O (Realty Income) and immediately ran it through the DRIP calculator. Bought 50 shares the next day.”
Reviews reflect users' personal experiences. Not financial advice.
Leave a review →